Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation

Show other versions (1)

Persistent thrombocytopenia is a frequent complication after allogeneic bone marrow transplantation (BMT). The major causes of thrombocytopenia include accelerated platelet destruction by antiplatelet antibodies, microangiopathy, viral infection, drug toxicity,graft`s hypofunction with insufficient...

Full description

Bibliographic Details
Main Authors: I. A. Lisukov, O. S. Uspenskaya, A. D. Kulagin, S. N. Bondarenko, T. A. Rudakova, O. A. Slesarchuk, B. V. Afanasyev
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkogematologiâ
Subjects:
romiplostim
thrombocytopenia
allogeneic bone marrow transplantation
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/67

Internet

https://oncohematology.abvpress.ru/ongm/article/view/67

Similar Items